ATE147990T1 - Erhöhung der assoziation exogener peptide mit mhci-molekülen auf zellen des immunsystems - Google Patents

Erhöhung der assoziation exogener peptide mit mhci-molekülen auf zellen des immunsystems

Info

Publication number
ATE147990T1
ATE147990T1 AT91910429T AT91910429T ATE147990T1 AT E147990 T1 ATE147990 T1 AT E147990T1 AT 91910429 T AT91910429 T AT 91910429T AT 91910429 T AT91910429 T AT 91910429T AT E147990 T1 ATE147990 T1 AT E147990T1
Authority
AT
Austria
Prior art keywords
antigen
microglobulin
cells
polypeptides
class
Prior art date
Application number
AT91910429T
Other languages
English (en)
Inventor
Kenneth L Rock
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE147990T1 publication Critical patent/ATE147990T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/605—MHC molecules or ligands thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Water Supply & Treatment (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Focusing (AREA)
  • Automatic Focus Adjustment (AREA)
  • Studio Devices (AREA)
AT91910429T 1990-05-10 1991-05-03 Erhöhung der assoziation exogener peptide mit mhci-molekülen auf zellen des immunsystems ATE147990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52157690A 1990-05-10 1990-05-10

Publications (1)

Publication Number Publication Date
ATE147990T1 true ATE147990T1 (de) 1997-02-15

Family

ID=24077258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910429T ATE147990T1 (de) 1990-05-10 1991-05-03 Erhöhung der assoziation exogener peptide mit mhci-molekülen auf zellen des immunsystems

Country Status (8)

Country Link
EP (1) EP0531401B1 (de)
JP (1) JPH05506447A (de)
AT (1) ATE147990T1 (de)
AU (1) AU660278B2 (de)
DE (1) DE69124372T2 (de)
DK (1) DK0531401T3 (de)
ES (1) ES2096650T3 (de)
WO (1) WO1991016924A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336758A (en) * 1990-03-09 1994-08-09 The United States Of America As Represented By The Department Of Health And Human Services Peptides stimulating cytotoxic T cells immune to HIV RT
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
GB9214871D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Vaccines
DE69418699T2 (de) * 1993-01-11 1999-09-30 Dana-Farber Cancer Institute, Boston Induktion der antworten zytotoxischer t-lymphozyten
GB9307371D0 (en) * 1993-04-08 1993-06-02 Walls Alan J Fusion proteins
EP0796280B1 (de) * 1994-12-28 2003-03-26 University Of Kentucky Monoklonaler anti-idiotypischer antikörper 3h1 aus maus
US6949244B1 (en) 1995-12-20 2005-09-27 The Board Of Trustees Of The University Of Kentucky Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
US20020041872A1 (en) 1996-04-12 2002-04-11 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6235280B1 (en) 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US6274143B1 (en) 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
US6682741B1 (en) 1998-06-10 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services β2 microglobulin fusion proteins and high affinity variants
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
EP2374470A1 (de) 2010-04-08 2011-10-12 Beta Innov Therapeutische Anwendung von Protein Beta-2-M

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860875D1 (en) * 1977-09-28 1981-10-15 Nat Res Dev Immunological preparations incorporating mhc antigens and their production
WO1980001986A1 (en) * 1979-03-27 1980-10-02 A Sanderson Improvements in or relating to immunological preparations

Also Published As

Publication number Publication date
EP0531401B1 (de) 1997-01-22
EP0531401A4 (en) 1993-07-14
DK0531401T3 (da) 1997-07-28
AU7987391A (en) 1991-11-27
WO1991016924A1 (en) 1991-11-14
EP0531401A1 (de) 1993-03-17
DE69124372D1 (de) 1997-03-06
JPH05506447A (ja) 1993-09-22
AU660278B2 (en) 1995-06-22
ES2096650T3 (es) 1997-03-16
DE69124372T2 (de) 1997-08-07

Similar Documents

Publication Publication Date Title
DE69124372D1 (de) Erhöhung der assoziation exogener peptide mit mhci-molekülen auf zellen des immunsystems
Weltzien et al. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions
Srivastava Heat shock proteins in immune response to cancer: the Fourth Paradigm
US5595881A (en) Method for the detection of antigen presenting cells
ATE180407T1 (de) Induktion der antworten zytotoxischer t- lymphozyten
Agrawal et al. In vitro induction of MUC-1 peptide-specific type 1 T lymphocyte and cytotoxic T lymphocyte responses from healthy multiparous donors
EP0997477A3 (de) MHC-Komplexe und ihre Verwendung
US20030077289A1 (en) Use of cell-penetrating peptides to generate antitumor immunity
BR9306820A (pt) Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero
CA2278189A1 (en) Peptides and peptide-loaded antigen presenting cells for the activation of ctl
KR20100028074A (ko) 세포 상해성 ｔ 림프구
Tomazic et al. Autoimmune murine thyroiditis. VIII. Role of different thyroid antigens in the induction of experimental autoimmune thyroiditis
Taieb et al. Dendritic cell-derived exosomes as cell-free peptide-based vaccines
Holen et al. Specific T cell lines for ovalbumin, ovomucoid, lysozyme and two OA synthetic epitopes, generated from egg allergic patients' PBMC
Lefrancier et al. Chemistry of synthetic immunomodulant muramyl peptides
Srivastava et al. Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases
Jackman et al. Mechanisms of lipid antigen presentation by CD1
Guimezanes et al. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product
Lane et al. Isolation of a murine liver‐specific alloantigen, F antigen, and examination of its immunogenic properties by radioimmunoassay
Curman et al. Presence of alloreactive Ia antigens on murine intestine epithelial cells
Schick et al. The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes
Salgaller Monitoring of cancer patients undergoing active or passive immunotherapy
Piersma et al. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: selection of sensitive assay criteria
Fukushima et al. Characterization of the immunopathogenic responses to ovalbumin peptide 323–339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats
AU775767B2 (en) Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation